P24 immunohistochemistry on lymphoid tissue: The histopathologist's role in HIV diagnosis: Commentary

Histopathology

Volumn 56, Issue 4, 2010, Pages 542-547

  Mahadeva, Ula ^a   Van Der Walt, Jon D ^a   Moonim, Mufaddal T ^a   Lucas, Sebastian B ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CHLORDANE; COMPLEMENT COMPONENT C3D RECEPTOR; PROTEIN S 100;

CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; FOLLICULAR DENDRITIC CELL; HEALTH CARE PERSONNEL; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MEDICAL ETHICS; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; PATHOLOGY, CLINICAL; PRACTICE GUIDELINES AS TOPIC;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77949579788     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03491.x     Document Type: Note

References (64)

1. Tenner-Rácz K, Rácz P, Dietrich M et al. Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS. AIDS 1987 1 95 104.
2. Kaluza G, Willems WR, Lohmeyer J et al. A monoclonal antibody that recognizes a formalin-resistant epitope on the p24 core protein of HIV-1. Pathol. Res. Pract. 1992 188 91 96.
3. Baroni CD, Pezzella F, Mirolo M et al. Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS). Histopathology 1986 10 5 13.
4. Tenner-Rácz K, Rácz P, Bofill M et al. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am. J. Pathol. 1986 123 9 15.
5. Spiegel H, Herbst H, Niedobitek G et al. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissue facilitating infection of CD4+ T-helper cells. Am. J. Pathol. 1992 140 15 22.
6. Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984 2 370 372.
7. Warner TF, Crass B, Gabel C et al. Diagnosis of HTLV-III infection by ultrastructural examination of germinal centres in lymph node - a case report. AIDS Res. 1986 2 43 50.
8. Alòs L, Navarrete P, Morente V et al. Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence. Mod. Pathol. 2005 18 127 136.
9. Dargent JL, Lespagnard L, Kornreich A et al. HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: a detailed study. Mod. Pathol. 2000 13 1293 1299.
10. Bell JE, Arango JC, Robertson R et al. HIV and drug misuse in the Edinburgh cohort. J. Acquir. Immune Defic. Syndr. 2002 31 (Suppl. 2 S35 S42.
11. Kuster H, Opravil M, Ott P et al. Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection. Am. J. Pathol. 2000 156 1973 1986.
12. Orenstein JM, Feinberg M, Yoder C et al. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS 1999 13 2219 2229.
13. Popovic M, Tenner-Rácz K, Pelser C et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 2005 102 14807 14812.
14. Tenner-Rácz K, Stellbrink HJ, van Lunzen J et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J. Exp. Med. 1998 187 949 959.
15. Orenstein JM, Bhat N, Yoder C et al. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression. AIDS 2000 14 1709 1715.
16. Wong JK, Günthard HF, Havlir DV et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl Acad. Sci. USA 1997 94 12574 12579.
17. Bhoopat L, Patanasakpinyo C, Yanaranop M, Bhoopat T. Clinico- immunopathological alterations of lymph nodes from human immunodeficiency virus-infected patients in northern Thailand. Asian Pac. J. Allergy Immunol. 1999 17 85 92.
18. Anderson DW, DeNobile J, Zhao F et al. Sampling lymph node content of human immunodeficiency virus type 1 nucleic acids and p24 antigen by fine-needle aspiration in early-stage patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995 10 (Suppl. 2 S57 S61.
19. Baroni CD, Vitolo D, Uccini S. Immunohistopathogenesis of persistent generalized lymphadenopathy in HIV-positive patients. Ric. Clin. Lab. 1990 20 1 10.
20. Porwit A, Bottiger B, Pallesen G et al. Follicular involution in HIV lymphadenopathy. A morphometric study. APMIS 1989 97 153 165.
21. O'Hara CJ, Groopman JE, Federman M. The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related and non-human immunodeficiency virus-related lymphadenopathy syndromes. Hum. Pathol. 1988 19 545 549.
22. Schuurman HJ, Krone WJ, Broekhuizen R, Goudsmit J. Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals. Am. J. Pathol. 1988 133 516 524.
23. Parmentier HK, van Wichen D, Sie-Go DM et al. HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells. Am. J. Pathol. 1990 137 247 251.
24. Pileri S, Rivano MT, Raise E et al. The value of lymph node biopsy in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex (ARC): a morphological and immunohistochemical study of 90 cases. Histopathology 1986 10 1107 1129.
25. Russano de Paiva G, Laurent C, Godel A et al. Discovery of human immunodeficiency virus infection by immunohistochemistry on lymph node biopsies from patients with unexplained follicular hyperplasia. Am. J. Surg. Pathol. 2007 31 1534 1538.
26. Voltersvik P, Bostad L, Dyrhol-Riise AM et al. Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2006 41 277 284.
27. Kapadia SB, Wiley CA, Soontornniyomkij V et al. HIV-associated Waldeyer's ring lymphoid hyperplasias: characterization of multinucleated giant cells and the role of Epstein-Barr virus. Hum. Pathol. 1999 30 1383 1388.
28. Orenstein JM, Wahl SM. The macrophage origin of the HIV-expressing multinucleated giant cells in hyperplastic tonsils and adenoids. Ultrastruct. Pathol. 1999 23 79 91.
29. Wenig BM, Thompson LD, Frankel SS et al. Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathological study of 12 cases. Am. J. Surg. Pathol. 1996 20 572 587.
30. Schuurman HJ, Krone WJ, Broekhuizen R et al. The thymus in acquired immune deficiency syndrome. Comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1. Am. J. Pathol. 1989 134 1329 1338.
31. Rivera H, Nikitakis NG, Castillo S et al. Histopathological analysis and demonstration of EBV and HIV p-24 antigen but not CMV expression in labial minor salivary glands of HIV patients affected by diffuse infiltrative lymphocytosis syndrome. J. Oral Pathol. Med. 2003 32 431 437.
32. Chetty R, Vaithilingum M, Thejpal R. Epstein-Barr virus status and the histopathological changes of parotid gland lymphoid infiltrates in HIV-positive children. Pathology 1999 31 413 417.
33. Uccini S, Riva E, Antonelli G et al. The benign cystic lymphoepithelial lesion of the parotid gland is a viral reservoir in HIV type1-infected patients. AIDS Res. Hum. Retroviruses 1999 15 1339 1344.
34. Labouyerie E, Merlio JP, Beylot-Barry M et al. Human immunodeficiency virus type 1 replication within cystic lymphoepithelial lesion of the salivary gland. Am. J. Clin. Pathol. 1993 100 41 46.
35. Bruner JM, Cleary KR, Smith FB, Batsakis JG. Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions. J. Laryngol. Otol. 1989 103 1063 1066.
36. Grassi MP, Clerici F, Vago L et al. Clinical aspects of the AIDS dementia complex in relation to histopathological and immunohistochemical variables. Eur. Neurol. 2002 47 141 147.
37. Nebuloni M, Pellegrinelli A, Ferri A et al. Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J. Neurovirol. 2000 6 46 50.
38. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 1995 38 563 570.
39. Schindelmeiser J, Gullotta F. HIV-p24-antigen-bearing macrophages are only present in brains of HIV-seropositive patients with AIDS-encephalopathy. Clin. Neuropathol. 1991 10 109 111.
40. Budka H. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol. (Berl.) 1990 79 611 619.
41. Geny C, Gherardi R, Boudes P et al. Multifocal multinucleated giant cell myelitis in an AIDS patient. Neuropathol. Appl. Neurobiol. 1991 17 157 162.
42. Rhodes RH, Ward JM, Cowan RP, Moore PT. Immunohistochemical localization of human immunodeficiency viral antigens in formalin-fixed spinal cords with AIDS myelopathy. Clin. Neuropathol. 1989 8 22 27.
43. Faber DW, Wiley CA, Lynn GB et al. Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients. Invest. Ophthalmol. Vis. Sci. 1992 33 2345 2353.
44. Schmitt-Graff A, Neuen-Jacob E, Rettig B, Sundmacher R. Evidence for cytomegalovirus and human immunodeficiency virus infection of the retina in AIDS. Virchows Arch. A. Pathol. Anat. Histopathol. 1990 416 249 253.
45. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies; similarities with seronegative polymyositis. Ann. Neurol. 1991 29 474 481.
46. Chetty R, Pillay SV. Coexistent gastric MALT lymphoma and Kaposi sarcoma in an HIV positive patient. J. Clin. Pathol. 1999 52 313 316.
47. Lewin-Smith M, Wahl SM, Orenstein JM. Human immunodeficiency virus-rich multinucleated giant cells in the colon: a case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization. Mod. Pathol. 1999 12 75 81.
48. Clayton F, Reka S, Cronin WJ et al. Rectal mucosal pathology varies with human immunodeficiency virus antigen content and disease stage. Gastroenterology 1992 103 919 933.
49. Kotler DP, Reka S, Borcich A, Cronin WJ. Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am. J. Pathol. 1991 139 823 830.
50. Hoda SA, White JE, Gerber MA. Immunohistochemical studies of human immunodeficiency virus-1 in liver tissues of patients with AIDS. Mod. Pathol. 1991 4 578 581.
51. Bhoopat L, Khunomornpong S, Sirivatanapa P et al. Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period. Mod. Pathol. 2005 18 1357 1364.
52. Chandwani S, Greco MA, Mittal K et al. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J. Infect. Dis. 1991 163 1134 1138.
53. Faulk WP, Labarrere CA. HIV proteins in normal human placentae. Am. J. Reprod. Immunol. 1991 25 99 104.
54. Nadasdy T, Hanson-Painton O, Davis LD et al. Conditions affecting the immunohistochemical detection of HIV in fixed and embedded renal and nonrenal tissues. Mod. Pathol. 1992 5 283 291.
55. Rogstad KE, Palfreeman A, Rooney G et al. United Kingdom national guidelines on HIV testing 2006. Clinical Effectiveness Group, British Association of Sexual Health and HIV. Available at http://www.bsah.org.uk. Last accessed 3 January 2009.
56. Dodds C, Weatherburn P. Reducing the length of time between HIV infection and diagnosis. BMJ 2007 334 1329 1330.
57. Brewster MF. HIV exceptionalism must end. (Letter). BMJ 2007 335 60.
58. UK National Guidelines for HIV Testing 2008. Prepared jointly by British HIV Association, British Association of Sexual Health and HIV & British Infection Society. Available at http://www.bhiva.org. Last accessed 3 January 2009.
59. The UK's appalling failure to tackle HIV. (Editorial.) Lancet 2009 373 1820.
60. Consent: patients and doctors making decisions together. General Medical Council 2008. Available at http://www.gmc-uk.org. Last accessed 3 January 2009.
61. Good medical practice in pathology. The Royal College of Pathologists 2002. Available at http://www.rcpath.org. Last accessed 1 March 2009.
62. Guidance on consent for the processing and analysis of clinical samples following an initial consultation. The Royal College of Pathologists 2009. Available at http://www.rcpath.org. Last accessed 1 March 2009.
63. McMillan A. The detection of genital tract infection by Papanicolaou-stained tests. Cytopathology 2006 17 317 322.
64. Lubinski C, Aberg J, Bardeguez AD et al. HIV policy: the path forward - a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians. Clinical Infectious Diseases 2009 48 1335 1344.